Brazilian Journal of Otorhinolaryngology

Brazilian Journal of Otorhinolaryngology (English Edition)

ISSN: 1808-8694

The Brazilian Journal of Otorhinolaryngology aims to provide timely information for physicians and scientists focused on otorhinolaryngology and head and neck disorders, including contemporary, ethical, clinically relevant information in:

- General otolaryngology;
- Head and neck surgery;
- Respiratory sleep disorders;
- Allergy/rhinology;
- Otology/neurotology;
- Laryngology/broncho-esophagology;
- Pediatric otolaryngology;
- Cranio-facial surgery;
- Skull base surgery;
- Head and neck oncology;
- Phoniatrics;
- Upper airway related diseases;
- Facial plastics and reconstructive surgery.

The journal is the official peer-reviewed open access scientific publication of the Brazilian Association of Otorhinolaryngology and Cervicofacial Surgery (ABORL-CCF).

All articles will be published under the CC-BY license (Creative Commons Attribution 4.0 International) with copyright owned by the ABORL-CCF.

Please note that articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication.

Indexed in:

MEDLINE/PubMed, Scopus, Web of Science/SCIE, DOAJ, Lilacs, SciELO, Qualis A3

•
Removal of necrotic bone is important in the treatment of medication- related osteonecrosis of the jaw.
•
Surgical treatment is more successful than conservative treatment in advanced stages (stage 2–3) of the medication- related osteonecrosis of the jaw.
•
Relatively less invasive and supportive treatments are recommended in patients with advanced medication- related osteonecrosis of the jaw.
•
Patient follow-up, good oral hygiene and patient motivation increase the success rate of the treatment.

Open access

Systemic immune inflammation index in patients with recurrent aphthous stomatitis

Fatma Atalay, Ayhan Kars, Kubra Topal, Zeynep Yavuz

Braz J Otorhinolaryngol. 2022;88:621-4

Highlights

•
RAS is a chronic, idiopathic, ulcerative oral mucosal disease.
•
SII is a new and inexpensive biomarker that can easily be calculated using the platelet, neutrophil, and lymphocyte count.
•
SII may be a valuable marker to demonstrate the role of systemic inflammation in RAS etiopathogenesis.
•
Vascular, thrombotic, and inflammatory processes are thought to have a role in RAS activation.

Open access

Review articles

Critical review of clinical practice guidelines for evaluation of neck mass in adults

Kevin Chorath, Aman Prasad, Neil Luu, Beatrice Go, Alvaro Moreira, Karthik Rajasekaran

Braz J Otorhinolaryngol. 2022;88:625-32

Open access

Oral changes in cocaine abusers: an integrative review

César Antonio Araújo Melo, Hanna Rabech Garcia Guimarães, Raphael Crhistian Fernandes Medeiros, Georgia Costa de Araújo Souza, Patrícia Bittencourt Dutra dos Santos, Ana Clara Soares Paiva Tôrres

Braz J Otorhinolaryngol. 2022;88:633-41

Highlights

•
Integrative review aiming to detect oral changes in cocaine abusers.
•
The main oral changes, methods of diagnosis and treatment were identified.
•
Good anamnesis and qualified health professionals are necessary.

Open access

Case reports

MALT lymphoma associated with laryngeal amyloidosis: case report

Leandro Castro Velasco, Laurice Barbosa Freitas, Jhessica Lima Garcia, Henrique Moura de Paula, Vitor Alves Cruz, Hugo Valter Lisboa Ramos, Claudiney Candido Costa

Braz J Otorhinolaryngol. 2022;88:642-5

Open access

Pedunculated pleomorphic adenoma of uvula – a rare presentation

Sabarinath Vijayakumar, Shilpa Divakaran, Suhail Muzaffar, Mohammed Yusuf Mian, Irfan Khan

Braz J Otorhinolaryngol. 2022;88:646-8

Open access

Indexed in:

Follow us:

Subscribe to our newsletter